QIAGEN launches QuantiFERON-EBV RUO assay, facilitating research of cell-mediated immune response to Epstein-Barr virus
Venlo, the Netherlands, Oct. 04, 2023 -- QIAGEN today announced the launch of its QuantiFERON-EBV RUO assay. Epstein-Barr virus , or human herpes virus 4, is estimated in various epidemiological...